CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • ÀÌÀ¯È£
  • ¼Ò ¼Ó: ºÐ´çÂ÷º´¿ø
  • Àü¹®ºÐ¾ß : ½ÅÀåÀ̽Ä/±Þ¼º½ÅÁúȯ/¸¸¼º½ÅÁúȯ/Ç÷´¢/´Ü¹é´¢/Åõ¼®
  • Á÷ À§: Á¶±³¼ö
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßžµ¿ 351¹øÁö
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ
14 (±¹¿Ü)SCI Reliability and Validity of the Korean Version of Kidney Disease Quality of Life Instrument (KDQOL-SFTM)
13 (±¹³»)±âŸ Activation of the renin-angiotensin system within podocytes in diabetes
12 (±¹³»)±âŸ Ç×°áÇÙÁ¦¿¡ ¹ÝÀÀÇÏÁö ¾Ê¾Ò´ø °áÇÙ¼º ¼ö¸·¿°°ú µ¿¹ÝÇÑ Ç×ÀÌ´¢È£¸£¸óºÎÀûÀýºÐºñÁõÈıº 1¿¹
11 (±¹³»)±âŸ ´ç´¢ ¹é¼­ »ç±¸Ã¼ ¹× °íÆ÷µµ´çÀ¸·Î ÀÚ±ØÇÑ Á·¼¼Æ÷¿¡¼­ ½ÎÀÌŬ·Î½ºÆ÷¸°ÀÌ P-cadherinÀÇ ¹ßÇö¿¡ ¹ÌÄ¡´Â ¿µÇâ
10 (±¹³»)±âŸ °íÆ÷µµ´çÀÌ Á·¼¼Æ÷³» ±¹¼Ò ·¹´Ñ-¾ÈÁö¿ÀÅٽŰè (Renin-Angiotensin system)¿¡ ¹ÌÄ¡´Â ¿µÇâ
9 (±¹¿Ü)SCI Influence of endothelial nitric oxide synthase gene polymorphisms (786TNC, 4a4b, 894GNT) in Korean patients with coronary artery disease
8 (±¹³»)KCI ¼ºÀÎÇü ½ºÆ¿º´°ú µ¿¹ÝµÈ Á¶Á÷±¸¼º ±«»ç¼º ¸²ÇÁÀý¿° 1¿¹
7 (±¹³»)KCI Mycoplasma Infection°ú µ¿¹ÝµÈ ±Þ¼º °£Áú¼º ½Å¿° 1¿¹
6 (±¹³»)KCI Å©·¹¸ÞÁøÀÇ Åõ¼®µµÀÔ Áö¿¬È¿°ú¿¡ µû¸¥ ÁøÇ༺ ½ÅºÎÀüÁõȯÀÚÀÇ ºñ¿ë°¨¼ÒºÐ Ãß°è
5 (±¹³»)KCI EPO »ç¿ëÀÌ ¾ø¾ú´ø ¸»±â½ÅºÎÀüÀ¸·Î Ç÷¾×Åõ¼® ÁßÀΠȯÀÚ¿¡¼­ ¹ß»ýÇÑ ÀûÇ÷±¸Áõ°¡Áõ 1¿¹
ÀÌÀüÆäÀÌÁö À̵¿ 11 12 13 14 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729